Market Cap | ₹7,992Cr |
ROE | 3.77% |
P/E Ratio(TTM) | 71.94 |
EPS(TTM) | 11.36 |
P/B Ratio | 3.37 |
Dividend Yield | 0.12% |
Industry P/E | 35.77 |
Book Value | 242.58 |
Debt to Equity | 0.25 |
Face Value | 1 |
Parent Organisation | Shilpa Medicare Limited |
Managing Director | Mr. Vishnukant Bhutada |
NSE Symbol | SHILPAMED |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.77 | ||
Gland Pharma | NA (0.00%) | 43.16 | ||
Ajanta Pharma | NA (0.00%) | 34.11 | ||
Eris Lifesciences | NA (0.00%) | 57.80 |